At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Concentration monitoring of antibiotics in plasmaother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Point-of-care Monitoring of Antibiotic Concentration in Blood With UV-VIS Absorption Spectroscopy
In Brief
An observational study evaluating Concentration monitoring of antibiotics in plasma for Sepsis and Infection, Bacterial. Completed, enrolled 36 participants across 1 site.
Detailed Summary
This prospective clinical study will investigate if antibiotic concentrations in patients with severe infections can be monitored by the UV-VIS spectroscopy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis, Infection, Bacterial
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 2020
Enrollment StartAug 2022
Primary CompletionJun 2023
Study CompletionAug 2023
TodayJul 2026
First PostedFeb 25, 2020
Enrollment StartAug 1, 2022
Primary CompletionJun 30, 2023
Study CompletionAug 10, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.4 years ago
Interventions
Concentration monitoring of antibiotics in plasmaother
Plasma antibiotic concentration will be measured using a bedside method with UV-VIS spectroscopy. These measurements will be validated with golden standard that is HPLC-MS.